As of April 2021, there are five commercially available chimeric antigen receptor (CAR) T
cell therapies for hematologic malignancies. With the current transition of CAR T cell …

The biophysical characteristics and counts of blood cells provide useful information
regarding pathological conditions. Therefore, the separation of blood components is a …

BACKGROUND The clinical and procedural parameters that affect the optimal collection of
lymphocytes for the production of chimeric antigen receptor (CAR) T cells remain undefined …

Terumo BCT recently introduced a new system for mononuclear cell (MNC) collection that
uses a Spectra Optia apheresis machine equipped with a redesigned disposable kit and …

Background and Objectives The Spectra Optia® continuous mononuclear cell (CMNC
apheresis) system has emerged as the preferred device in peripheral blood stem cell …

Apheresis is at the forefront of therapeutic approaches for an increasing number of
indications caused by formation of pathologic antibodies treated by therapeutic plasma …

Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a
mainstay of treatment for various types of malignancies. This study aimed to evaluate the …

Background Large‐volume leukapheresis (LVL) refers to processing of more than three
volumes of blood in a single session for peripheral blood stem cell collection. Recently …

In the clinical setting, a blood sample is typically the starting point for biomarker search and
discovery. Mass spectrometry (MS) is a highly sensitive and informative method for …

Simple Summary We retrospectively reviewed data from cancer patients undergoing
peripheral blood stem cell (PBSC) collection following different mobilization regimens (with …